MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

OBJECTIVE: To optimize sensitivity and disease specificity of a myelin oligodendrocyte glycoprotein (MOG) antibody assay. METHODS: Consecutive sera (n = 1,109) sent for aquaporin-4 (AQP4) antibody testing were screened for MOG antibodies (Abs) by cell-based assays using either full-length human MOG...

Descripción completa

Detalles Bibliográficos
Autores principales: Waters, Patrick, Woodhall, Mark, O'Connor, Kevin C., Reindl, Markus, Lang, Bethan, Sato, Douglas K., Juryńczyk, Maciej, Tackley, George, Rocha, Joao, Takahashi, Toshiyuki, Misu, Tatsuro, Nakashima, Ichiro, Palace, Jacqueline, Fujihara, Kazuo, Leite, M. Isabel, Vincent, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370386/
https://www.ncbi.nlm.nih.gov/pubmed/25821844
http://dx.doi.org/10.1212/NXI.0000000000000089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370386/
https://www.ncbi.nlm.nih.gov/pubmed/25821844
http://dx.doi.org/10.1212/NXI.0000000000000089

Ejemplares similares